Alexion Pharmaceuticals, Inc. (ALXN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Alexion Pharmaceuticals, Inc. (ALXN)

ALXN 182.50

0.0%

Jul 28 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jongmans who wrote (29)	9/24/1999 12:53:00 AM
From: Larry Liebman	Read Replies (1) of 824

Piper Jaffray made bullish statements in favor of ALXN. Suggested that success in any of Phase 2 trials could double valuation. Raised initial target from $19 to $25. Another intriguing biotech. 11 million+ sh. out/$175 million valuation. Products in trials address significant markets. Worth some due diligence. P.S. Notice the amount of noise on this thread

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next